What's Going On With Summit Therapeutics Stock On Monday? - Summit Therapeutics (NASDAQ:SMMT)

Summit Therapeutics' new ivonescimab trial results showed a survival benefit in lung cancer and encouraging data in colorectal cancer.

Raccontata dabenzinga.com